Key Finding
Complementary therapies including acupuncture show evidence-based promise for treating depression, anxiety, and PTSD, yet most healthcare providers remain unaware of their patients' use of these modalities or the supporting research.
Mental health conditions like depression, anxiety, and PTSD affect millions of Americans, yet many people don't receive treatment or find that medications and traditional therapy don't work well for them. This review examined the scientific evidence for complementary therapies—including acupuncture, meditation, and natural supplements—as treatment options for common mental health disorders.
The researchers found that many patients are already using these complementary approaches, often without telling their doctors. However, most healthcare providers aren't familiar with the research supporting these treatments. The review focused on three major conditions: depression, anxiety disorders, and post-traumatic stress disorder (PTSD).
For patients considering acupuncture specifically, the evidence suggests it may be a helpful addition to conventional treatment. Acupuncture has shown promise particularly for depression and anxiety, with studies indicating it can help reduce symptoms and improve overall wellbeing. The therapy appears to work by influencing brain chemistry and nervous system function, helping to regulate mood and stress responses.
What this means for you: If you're struggling with a mental health condition and haven't found adequate relief from conventional treatments alone, acupuncture and other complementary therapies may be worth discussing with your healthcare team. These approaches can often be used safely alongside medication and psychotherapy. Many patients find that combining conventional and complementary treatments provides better results than either approach alone.
It's important to note that complementary therapies work best as part of a comprehensive treatment plan, not as replacements for proven treatments. If you're considering acupuncture for a mental health condition, seek care from a licensed acupuncturist with experience treating mental health disorders.
This review examines evidence-based recommendations for complementary therapies in treating depression, anxiety, and PTSD, addressing a significant treatment gap given that only 13% of the 18% of US adults with mental illness receive care. The article highlights the widespread but often undisclosed use of complementary modalities including acupuncture, meditation, and natural products among patients experiencing treatment discontinuation or failure with conventional pharmacotherapy and psychotherapy.
The review emphasizes that many clinicians lack knowledge of the evidence base supporting these interventions, despite their increasing utilization. While specific sample sizes and effect sizes are not detailed in this overview article, the authors present current evidence supporting acupuncture and other complementary approaches for mood and anxiety disorders.
Clinical takeaway: Acupuncture represents a viable adjunctive or alternative treatment option for patients with depression, anxiety, and PTSD, particularly those who are treatment-resistant, experience adverse effects from pharmacotherapy, or prefer integrative approaches. Clinicians should proactively discuss complementary therapy use with mental health patients and consider evidence-based complementary modalities in comprehensive treatment planning.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Manual acupuncture significantly reduced anxiety symptoms post-treatment compared to both sham acupuncture and usual care, with effects sustained at follow-up versus sham acupuncture but not usual care.
📌 This is a systematic review protocol outlining plans to evaluate MSRT's effects on anxiety, sleep quality, and quality of life in adults, but does not yet contain actual findings from completed research.
📌 Acupuncture combined with SSRI/SNRI medications significantly reduced anxiety scores in somatic symptom disorder patients at 4 weeks compared to medication alone, though evidence quality was low and pain outcomes showed no significant benefit.